RWK:NYE-Invesco S&P MidCap 400 Revenue ETF (USD)

ETF | Mid-Cap Value |

Last Closing

USD 115

Change

-0.52 (-0.45)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Mid-Cap Value

Symbol Name Price(Change) Market Cap
VOE Vanguard Mid-Cap Value Index F..

-0.41 (-0.25%)

USD 18.00B
IWS iShares Russell Mid-Cap Value ..

-0.24 (-0.18%)

USD 13.48B
IJJ iShares S&P Mid-Cap 400 Value ..

+0.10 (+0.08%)

USD 7.75B
KOMP SPDR Kensho New Economies Comp..

+0.21 (+0.43%)

USD 2.03B
PVAL Putnam Focused Large Cap Value..

N/A

USD 1.19B
IVOV Vanguard S&P Mid-Cap 400 Value..

+0.05 (+0.05%)

USD 0.93B
XMLV Invesco S&P MidCap Low Volatil..

N/A

USD 0.83B
DIV Global X SuperDividend U.S. ET..

-0.07 (-0.35%)

USD 0.65B
VUSE Vident Core U.S. Equity Fund

+0.27 (+0.47%)

USD 0.58B
XMVM Invesco S&P MidCap Value with ..

-0.07 (-0.13%)

USD 0.26B

ETFs Containing RWK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Value) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.49% 50% F 55% F
Dividend Return 0.92% 23% F 16% F
Total Return 10.41% 43% F 48% F
Trailing 12 Months  
Capital Gain 26.21% 63% D 65% D
Dividend Return 1.38% 20% F 17% F
Total Return 27.59% 50% F 60% D-
Trailing 5 Years  
Capital Gain 98.41% 100% F 84% B
Dividend Return 5.82% 20% F 17% F
Total Return 104.23% 100% F 83% B
Average Annual (5 Year Horizon)  
Capital Gain 19.91% N/A N/A 83% B
Dividend Return 20.67% N/A N/A 81% B-
Total Return 0.76% N/A N/A 18% F
Risk Return Profile  
Volatility (Standard Deviation) 30.16% N/A N/A 34% F
Risk Adjusted Return 68.53% N/A N/A 82% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike